These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 34601272

  • 1. Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
    De Aquino JP, Parida S, Avila-Quintero VJ, Flores J, Compton P, Hickey T, Gómez O, Sofuoglu M.
    Drug Alcohol Depend; 2021 Nov 01; 228():109097. PubMed ID: 34601272
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Utilization of buprenorphine and methadone among opioid users who inject drugs.
    Tsui JI, Burt R, Thiede H, Glick SN.
    Subst Abus; 2018 Jan 02; 39(1):83-88. PubMed ID: 28796591
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment.
    Arnet I, Dürsteler KM, Jaiteh C, Grossmann F, Hersberger KE.
    Eur Addict Res; 2023 Jan 02; 29(4):253-263. PubMed ID: 37302389
    [Abstract] [Full Text] [Related]

  • 6. Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
    Thakrar AP, Uritsky TJ, Christopher C, Winston A, Ronning K, Sigueza AL, Caputo A, McFadden R, Olenik JM, Perrone J, Delgado MK, Lowenstein M, Compton P.
    Addict Sci Clin Pract; 2023 Feb 24; 18(1):13. PubMed ID: 36829242
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.
    Smith K, Wang M, Abdukalikov R, McAullife A, Whitesell D, Richard J, Sauer W, Quaye A.
    J Clin Pharmacol; 2022 Apr 24; 62(4):449-462. PubMed ID: 34775634
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
    Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA.
    J Gen Intern Med; 2022 Aug 24; 37(11):2786-2794. PubMed ID: 34981359
    [Abstract] [Full Text] [Related]

  • 11. Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
    Manhapra A, Stefanovics E, Rosenheck R.
    Subst Abus; 2020 Aug 24; 41(1):110-120. PubMed ID: 31403914
    [Abstract] [Full Text] [Related]

  • 12.
    ; 2012 Aug 24. PubMed ID: 31643200
    [Abstract] [Full Text] [Related]

  • 13. Managing Acute Pain in Patients Taking Medication for Opioid Use Disorder: a Rapid Review.
    Veazie S, Mackey K, Peterson K, Bourne D.
    J Gen Intern Med; 2020 Dec 24; 35(Suppl 3):945-953. PubMed ID: 33145688
    [Abstract] [Full Text] [Related]

  • 14. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L, Sonne NM, Madsen SL, Nikolajsen L.
    Ugeskr Laeger; 2015 Mar 02; 177(10):. PubMed ID: 25749118
    [Abstract] [Full Text] [Related]

  • 15. Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.
    Brothers TD, Fraser J, MacAdam E, Morgan B, Webster D.
    Drug Alcohol Rev; 2022 Feb 02; 41(2):430-434. PubMed ID: 34347327
    [Abstract] [Full Text] [Related]

  • 16. Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study.
    Pinhal M, Schreck B, Leboucher J, STIGMA-group, Victorri-Vigneau C, Laforgue EJ, Grall-Bronnec M.
    Addict Sci Clin Pract; 2024 Oct 16; 19(1):74. PubMed ID: 39415293
    [Abstract] [Full Text] [Related]

  • 17. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
    Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR.
    Pain Physician; 2021 Mar 16; 24(2):E249-E256. PubMed ID: 33740362
    [Abstract] [Full Text] [Related]

  • 18. Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial.
    Mocanu V, Bozinoff N, Wood E, Jutras-Aswad D, Le Foll B, Lim R, Cheol Choi J, Yin Mok W, Eugenia Socias M, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse.
    Drug Alcohol Depend; 2023 Jul 01; 248():109932. PubMed ID: 37224674
    [Abstract] [Full Text] [Related]

  • 19. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC, Crabtree A, Nolan S, Mok WY, Cui Z, Chong M, Slaunwhite A, Ti L.
    PLoS Med; 2022 Dec 01; 19(12):e1004123. PubMed ID: 36454732
    [Abstract] [Full Text] [Related]

  • 20. Opioids for cancer pain - an overview of Cochrane reviews.
    Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA.
    Cochrane Database Syst Rev; 2017 Jul 06; 7(7):CD012592. PubMed ID: 28683172
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.